COMMITMENTS AND CONTINGENCIES (Details Narrative)				3 Months Ended		9 Months Ended		12 Months Ended
	Mar. 01, 2018 $ / shares shares	Feb. 12, 2018 USD ($) $ / shares shares	Aug. 12, 2016 USD ($) shares	Sep. 30, 2018 USD ($)	Sep. 30, 2017 USD ($)	Sep. 30, 2018 USD ($)	Sep. 30, 2017 USD ($)	Dec. 31, 2017 shares
Number of option granted								4,000,000
Net proceeds equity financing | $						$ 1,000,000
354 Merrimack Street, Lawrence MASSACHUSETTS
Rent expense | $				$ 900	$ 900	2,700	$ 2,700
The BioScience Center 5901 Indian School Rd., Albuquerque NEW MEXICO
Rent expense | $				1,281		3,450
Contribution Agreement [Member] | CureDM Group Holdings, LLC [Member]
Number of shares issued		47,741,140
Number of shares issued at time of delivered		25,000,000
Number of shares issued at time of milestone		22,741,140
Number of shares issued per tranche		5,685,285
Number of tranches for delivered		4
Number of shares issued upon contingent liability , value | $		$ 1,137,057		$ 1,137,057		$ 1,137,057
Mr. Carl W. Rausch [Member]
Number of option granted	6,000,000
Share price (in dollars per share) | $ / shares	$ 0.10
Description of reduction in exercise price	<p><font style="font: 10pt Times New Roman, Times, Serif">First tranche of 2,000,000 will be exercisable at $0.10 per share and the second and third tranches of 2,000,000 will be exercisable at $0.15 per share.</font></p>
Mr. Carl W. Rausch [Member] | Employment Agreement [Member]
Amount of signing bonus | $			$ 60,000
Agreement term			3 years
Annual salary | $			$ 224,000
Increase in annual salary upon relocating United States | $			264,000
Increase in annual salary upon company listed on a national exchange | $			$ 20,000
Mr. Carl W. Rausch [Member] | Employment Agreement [Member] | Stock Option [Member]
Number of option granted			6,000,000
Expiration period			5 years
Description of vesting			<p style="margin: 0pt"><font style="font: 10pt Times New Roman, Times, Serif">Earned and vested in three equal tranches of 2,000,000 upon the Company raising $1,000,000 in financing, the Company raising $5,000,000 in financing and the Company entering into a significant corporate alliance for substantial marketing and selling of the Company’s product portfolio. The initial tranche shall be exercisable at $0.20 per share, the second tranche will be $0.40 per share and the third tranche shall be $0.60 per share</font></p>
Ms. Loraine Upham [Member]
Annual salary | $		$ 200,000
Description of accrual salary and bonus after achieving certain milestone		<p><font style="font: 10pt Times New Roman, Times, Serif">Ms. Upham’s salary shall accrue until the Company has raised a minimum of $1,250,000. Ms. Upham is eligible for bonuses as determined by the Board of Directors. These include a bonus of $20,000 is to be paid upon the Company successfully raising $1,250,000 through the sale of equity; an annual performance bonus based on milestones related to clinical progress, partnering and fund raising success to be established by the Board of Directors or the Compensation Committee, if in existence on an annual basis.</font></p>
Ms. Loraine Upham [Member] | 2011 Stock Plan [Member]
Number of option granted		4,000,000
Expiration period		5 years
Vesting period		3 years
Ms. Loraine Upham [Member] | 2011 Stock Plan [Member] | Tranche One [Member]
Number of option granted		1,333,334
Share price (in dollars per share) | $ / shares		$ 0.06
Ms. Loraine Upham [Member] | 2011 Stock Plan [Member] | Tranche Two [Member]
Number of option granted		1,333,334
Share price (in dollars per share) | $ / shares		$ 0.10
Ms. Loraine Upham [Member] | 2011 Stock Plan [Member] | Tranche Three [Member]
Number of option granted		1,333,334
Share price (in dollars per share) | $ / shares		$ 0.20